[go: up one dir, main page]

RU2018137590A3 - - Google Patents

Download PDF

Info

Publication number
RU2018137590A3
RU2018137590A3 RU2018137590A RU2018137590A RU2018137590A3 RU 2018137590 A3 RU2018137590 A3 RU 2018137590A3 RU 2018137590 A RU2018137590 A RU 2018137590A RU 2018137590 A RU2018137590 A RU 2018137590A RU 2018137590 A3 RU2018137590 A3 RU 2018137590A3
Authority
RU
Russia
Application number
RU2018137590A
Other versions
RU2018137590A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018137590A publication Critical patent/RU2018137590A/ru
Publication of RU2018137590A3 publication Critical patent/RU2018137590A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
RU2018137590A 2016-03-26 2017-03-27 Фармацевтические композиции для производного n-пропаргиламина RU2018137590A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201641006786 2016-03-26
IN201641006786 2016-03-26
PCT/IB2017/000402 WO2017168244A1 (en) 2016-03-26 2017-03-27 Pharmaceutical compositons for n-propargylamine derivative

Publications (2)

Publication Number Publication Date
RU2018137590A RU2018137590A (ru) 2020-04-27
RU2018137590A3 true RU2018137590A3 (ru) 2020-04-27

Family

ID=58670102

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018137590A RU2018137590A (ru) 2016-03-26 2017-03-27 Фармацевтические композиции для производного n-пропаргиламина

Country Status (5)

Country Link
US (2) US10292947B2 (ru)
EP (1) EP3432931A1 (ru)
CN (1) CN109152841A (ru)
RU (1) RU2018137590A (ru)
WO (1) WO2017168244A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021026509A2 (pt) * 2019-07-01 2022-02-15 Univ Shenyang Chemical Tech Composto de isoxazolina, seu método de preparação e sua aplicação
US12161755B2 (en) * 2020-11-14 2024-12-10 Regents Of The University Of Minnesota Sustained release device for treatment of Parkinson's disease and other disorders
US20240115492A1 (en) * 2021-01-30 2024-04-11 Intas Pharmaceuticals Ltd. An orodispersible pharmaceutical solid dosage form of rasagiline
EP4035654A1 (en) * 2021-01-30 2022-08-03 Intas Pharmaceuticals Limited An orodispersible pharmaceutical solid dosage form of rasagiline
CN118141772B (zh) * 2024-03-08 2024-09-10 四川鲁徽制药有限责任公司 盐酸罗匹尼罗甲磺酸雷沙吉兰复方口崩控释片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
AU702161B2 (en) 1995-03-02 1999-02-18 R.P. Scherer Limited Pharmaceutical compositions comprising monoamine oxidase B inhibitors
ES2371883T3 (es) * 2004-11-24 2012-01-11 Teva Pharmaceutical Industries Ltd. Composiciones de rasagilina de disgregación oral.
WO2006058250A2 (en) 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
CN1911211B (zh) * 2006-08-25 2010-04-14 重庆医药工业研究院有限责任公司 雷沙吉兰口服固体制剂
EP2170282A4 (en) 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
EP2296462A4 (en) * 2008-06-13 2011-06-15 Teva Pharma RASAGILINE FOR INFLUENCING MORBUS PARKINSON
CA2754089A1 (en) * 2009-03-05 2010-09-10 Sandoz Ag Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (1r)-, methanesulfonate
WO2010111264A2 (en) 2009-03-24 2010-09-30 Dr. Reddy's Laboratories Ltd. Rasagiline formulations
CN101874790B (zh) * 2009-04-29 2012-06-06 齐鲁制药有限公司 雷沙吉兰或者其药用盐口腔崩解片及其制备方法
AU2010274589A1 (en) * 2009-07-23 2012-02-16 Alkem Laboratories Ltd. Oral pharmaceutical composition of rasagiline and process for preparing thereof

Also Published As

Publication number Publication date
RU2018137590A (ru) 2020-04-27
CN109152841A (zh) 2019-01-04
US10292947B2 (en) 2019-05-21
US20170273918A1 (en) 2017-09-28
WO2017168244A1 (en) 2017-10-05
US20190224143A1 (en) 2019-07-25
US10842759B2 (en) 2020-11-24
EP3432931A1 (en) 2019-01-30

Similar Documents

Publication Publication Date Title
BR122021013712A2 (ru)
BR122020022459A2 (ru)
BR112019009192A2 (ru)
RU2018137590A3 (ru)
BR112019006736A2 (ru)
BR202016025584U2 (ru)
BR202016021516U2 (ru)
CN303563185S (ru)
CN303539132S (ru)
CN303629633S (ru)
CN303629193S (ru)
CN303628395S (ru)
CN303649285S (ru)
CN303628388S (ru)
CN303622627S (ru)
CN303622101S (ru)
CN303621437S (ru)
CN303616457S (ru)
CN303670653S (ru)
CN303608261S (ru)
CN303591885S (ru)
CN303581052S (ru)
CN303538170S (ru)
CN303567126S (ru)
CN303538457S (ru)

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20220121